Welcome to our dedicated page for Lam Research SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lam Research Corp. filings document regulatory disclosures for a semiconductor wafer fabrication equipment company. Its Form 8-K reports include operating results and financial-condition updates, material-event disclosures, exhibits for quarterly earnings releases, governance matters, capital-structure items, and changes affecting security-holder rights.
Lam Research proxy and related filings cover annual meeting proposals, director elections, executive compensation advisory votes, stock incentive plan approvals, auditor ratification, charter amendments, stockholder proposals, and changes in the company’s independent registered public accounting firm.
Lam Research Corp director Abhijit Y. Talwalkar executed an open-market sale of 18,282 shares of Common Stock on July 13, 2026 at $335.0000 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026. Following the transaction, he directly owns 87,142 shares, which include shares subject to unvested restricted stock units.
A holder of common stock of LRCX has filed a notice of proposed sales under Rule 144. The filing lists up to 18,282 shares, with an indicated aggregate market value of $6,124,470.00, to be sold through Fidelity Brokerage Services LLC on or after July 13, 2026 on the NASDAQ market.
The shares relate to prior restricted stock vesting events received from the issuer as compensation on several dates between 2014 and 2025.
LAM Research President and CEO Timothy Archer exercised employee stock options and sold shares in an open-market transaction. He exercised options for 30,000 shares of common stock at $30.033 per share and sold 30,000 shares at $390.01 per share on July 2, 2026.
After these transactions, Archer directly owned 1,075,966 shares of LAM Research common stock, with additional indirect holdings in his and his spouse’s 401(k) accounts. The filing notes that the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on February 24, 2026, and that his reported holdings include shares tied to unvested restricted stock units.
Lam Research Corp director Eric Brandt reported open-market sales of 54,500 shares of common stock on June 12, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 6, 2026, at prices ranging from $355.39 to $373.36 per share. Following these transactions, he directly owns 198,905 shares, including shares subject to unvested restricted stock units.
LAM RESEARCH CORP director Eric Brandt reported a series of open‑market sales of company common stock. On June 11, 2026, he sold a total of 54,500 shares in multiple transactions under a pre‑arranged Rule 10b5‑1 trading plan adopted on February 6, 2026.
The reported weighted‑average sale prices for these trades ranged from about $337 to $364 per share. Following the transactions, Brandt directly owned 199,205 shares of Lam Research common stock, and this amount includes shares subject to unvested restricted stock units.
LRCX notice on Form 144 reports an intended sale of 54,500 shares of Common Stock, with the filing dated 06/12/2026 and Nasdaq as the exchange. The filing lists Fidelity Brokerage Services LLC with an address and shows the shares originate from two restricted‑stock vesting events dated 01/31/2014 (26,250 shares) and 10/31/2014 (28,250 shares).
Company: The filing reports proposed sales of 54,500 shares of Common Stock under Rule 144. The notice names Fidelity Brokerage Services LLC and lists an aggregate amount of $19,118,337.80 alongside a date of 06/11/2026. The excerpt also lists prior restricted stock vesting events of 29,480, 12,970, and 12,050 shares dated 01/25/2013, 11/04/2013, and 01/31/2014, respectively.
Neil J. Fernandes, Senior Vice President of LAM RESEARCH CORP, sold 7,659 shares of common stock at $309.60 per share in an open-market transaction pursuant to a Rule 10b5-1 trading plan. He now holds 58,470 shares directly and 1,015.395 shares indirectly through a 401(k) plan.
LRCX: Notice of proposed resale of Common Stock under Rule 144 by Fidelity Brokerage Services LLC and a reporting person. The filing lists 7,659 shares of Common Stock associated with a restricted stock vesting event dated 03/01/2025. It also reports prior sales of 18,170 shares on 05/01/2026 for $4,635,893.80. The form identifies the broker-dealer and lists an as-of date of 06/01/2026.